Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000276288 | SCV000399296 | likely benign | Brittle cornea syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000421347 | SCV000511062 | benign | not provided | 2016-12-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000421347 | SCV000730944 | benign | not provided | 2019-03-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000421347 | SCV001722280 | benign | not provided | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000276288 | SCV002514261 | benign | Brittle cornea syndrome 1 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278442 | SCV002565309 | benign | Ehlers-Danlos syndrome | 2022-06-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002450879 | SCV002736118 | benign | Cardiovascular phenotype | 2019-05-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000421347 | SCV005212233 | likely benign | not provided | criteria provided, single submitter | not provided |